Source: http://www.thefederalregister.com/d.p/2003-05-29-03-13378
Timestamp: 2013-05-25 04:49:15
Document Index: 234304609

Matched Legal Cases: ['art 7114', 'art 3944', 'art 6726', 'art 140', 'art 5250', 'art 1739', 'art 30206', 'art 514', 'art 9740', 'art 180', 'art 46']

Anniston, AL; polychlorinated biphenyls exposure and adverse health effects, Daily Rules, Proposed Rules, and Notices of the Federal Government
14 CFR Part 7114 CFR Part 3944 CFR Part 6726 CFR Part 140 CFR Part 5250 CFR Part 1739 CFR Part 30206 CFR Part 514 CFR Part 9740 CFR Part 180	Federal Register: May 29, 2003 (Volume 68, Number 103)
DOCID: FR Doc 03-13378
DOCUMENT ID: [Program Announcement Number 03087]
SUBJECT CATEGORY: Polychlorinated Biphenyls Exposure and Adverse Health Effects in Anniston, Alabama; Notice of Availability of Funds DOCUMENT SUMMARY: Application Deadline: June 30, 2003.
This program is authorized in Sections 104(i)(1)(E), (7) and (15) of the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) as amended by the Superfund Amendments and Reauthorization Act (SARA) (42 U.S.C. 9604 (i)(1)(E), (7) and (15)). The Catalog of Federal Domestic Assistance number is 93.206. [[Page 32051]]
The Agency for Toxic Substances and Disease Registry (ATSDR) announces the availability of fiscal year (FY) 2003 funds for a cooperative agreement program to conduct research on the impact of polychlorinated biphenyls (PCBs) exposure on human health in Anniston, Alabama. This program addresses the ``Healthy People 2010'' focus area of Environmental Health. The purpose of this program is to: (1) Collect baseline information and serum PCBs from a sample of Anniston residents; (2) study the relationship between exposure to PCBs and adverse health effects, such as cancer, neurobehavioral disorders, birth defects, and immune function; and (3) inform and educate residents about PCB exposure in their community. Measurable outcomes of the program will be in alignment with one or more of the following performance goals for the ATSDR: (1) develop and provide reliable and understandable information for people in affected communities and tribes, and for stakeholders, and (2) ascertain the relationship between exposure to toxic substances and disease. C. Eligible Applicants Applications may be submitted by:
[sbull] Health departments of States or their bona fide agents, including the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau.
[sbull] Federally recognized Indian tribal governments.
[sbull] Statebased institutions (this includes universities, colleges, and research institutions. Note: Title 2 of the United States Code section 1611 states that an organization described in section 501(c)(4) of the Internal Revenue Code that engages in lobbying activities is not eligible to receive Federal funds constituting an award, grant or loan. Special Requirements
1. A documented link between the Anniston community and the applicant. 2. Experience with community outreach and health education to provide support and information. 3. The investigators should be prepared to work collaboratively with ATSDR and community leaders to achieve the goals of this solicitation. 4. The investigators should be prepared to meet on a periodic basis with community representatives. D. Funding
Approximately $1,500,000 is available in FY 2003 to fund up to two awards. It is expected that the average award will be $750,000, ranging from $600,000 to $1,500,000. It is expected that the awards will begin on or about August 1, 2003, and will be made for a 12month budget period within a project period of up to three years. Funding estimates may change. Continuation awards within an approved project period will be made on the basis of satisfactory progress as evidenced by required reports and the availability of funds.
Matching funds are not required for this program. Funding Preferences Preference will be given to the following: applicants who are located in the southeastern region of the United States, applicants who have support from the Anniston community as evidenced by letters of support, applicants who demonstrate collaborative effort with other institutions, or projects which avoid a duplication of study objectives.
c. At the conclusion of the study, share all data collected through these activities with ATSDR. These data may be used by ATSDR to further characterize potential exposure pathways. d. Through letters of support, provide evidence of ongoing collaborative efforts with community representatives, local elected officials, state and local health departments, etc., to enhance communication and information exchange with the Anniston community (Attachment V). e. Establish a mechanism to work with community leaders in Anniston, Alabama, on a periodic basis throughout the study period to gather input on study design issues, and receive feedback regarding outreach, participation, and education. f. Meet annually with ATSDR and other awardee(s) in Atlanta, Georgia, to coordinate planned efforts and review progress.
a. Provide epidemiologic guidance and administrative support to achieve program goals. b. In collaboration with the recipient, develop a research protocol for Institutional Review Board (IRB) review by all cooperating institutions [[Page 32052]]
participating in the research project. The CDC IRB will review and approve the protocol initially and on at least an annual basis until the research project is completed. c. Develop and provide to recipient a number of baseline questions for data collection related to the participant's exposure history.
d. In collaboration with the Environmental Protection Agency Region IV and the recipient(s), coordinate meetings in Anniston, Alabama, at least twice in the first year to review available exposure data to better define exposed population(s). e. Participate in periodic meetings with community leaders in Anniston, Alabama, to gather input on study design issues, and receive feedback regarding outreach, participation, and education throughout the study period. f. Facilitate external peer review of the study protocol and the final report. g. Provide assistance with the dissemination of information resulting from this project, including the review and publication of a final report. h. Facilitate an annual meeting between awardee(s) in Atlanta, Georgia, to coordinate planned efforts and review progress. F. Content
The Program Announcement title and number must appear in the application. Use the information in the Program Requirements, Other Requirements, and Evaluation Criteria sections to develop the application content. Your application will be evaluated on the criteria listed, so it is important to follow them in laying out your program plan. The narrative should be no more than 45 pages, doublespaced, printed on one side, with oneinch margins, and unreduced 12point font. The narrative should consist of, at a minimum, a Proposed Research Plan, Objectives, Methods, Evaluation, Budget, and Time line. The program plan should address activities to be conducted over the entire threeyear project period. G. Submission and Deadline
Submit the signed original and two copies of PHS 51611 (OMB 0920
0428). Forms are available at the following Internet address: http://www.cdc.gov/od/pgo/forminfo.htm. If you do not have access to the Internet, or if you have difficulty accessing the forms online, you may contact the CDC Procurement and Grants Office Technical Information Management Section (PGOTIM) at: 7704882700. Application forms can be mailed to you.
The application must be received by 4 p.m. eastern time June 30, 2003. Submit the application to: Technical Information ManagementPA 03087, Procurement and Grants Office, Centers for Disease Control and Prevention, 2920 Brandywine Rd, Atlanta, GA 303414146.
Applications may not be submitted electronically. CDC Acknowledgment of Application Receipt A postcard will be mailed by PGOTIM, notifying you that CDC has received your application.
Applications shall be considered as meeting the deadline if they are received before 4 p.m. eastern time on the deadline date. Any applicant who sends their application by the United States Postal Service or commercial delivery services must ensure that the carrier will be able to guarantee delivery of the application by the closing date and time. If an application is received after closing due to (1) carrier error, when the carrier accepted the package with a guarantee for delivery by the closing date and time, or (2) significant weather delays or natural disasters, CDC will upon receipt of proper documentation, consider the application as having been received by the deadline. Any application that does not meet the above criteria will not be eligible for competition, and will be discarded. The applicant will be notified of their failure to meet the submission requirements. H. Evaluation Criteria
a. Adequacy of the study design and methodology for accomplishing the stated goals and objectives. b. The degree to which efficient and innovative approaches are proposed in collaboration with other institutions. c. The extent to which the applicant's plans and schedule proposed for accomplishing the activities to be carried out in this project are clearly stated, are realistic given the length of the funding period, and can be achieved within the proposed budget. d. Applicant provides opportunities to collaborate with Anniston community leaders to develop final study protocol.
3. Community Involvement, Education, and Dissemination of Results (20 percent) a. Adequacy of plan to address community concerns by establishing partnerships with community representatives, local environmental and health agencies, and other relevant public and private groups and organizations prior to project implementation. b. Adequacy of plans to create formal lines of communication with Anniston leaders on a periodic basis, including representation from various disciplines and backgrounds. c. The degree to which efficient and innovative approaches are proposed to educate the community about PCB exposure. d. Adequacy of methods to work with the community to disseminate study results.
a. The applicant's understanding of the problems facing the residents of Anniston, Alabama. b. The applicant should demonstrate an understanding of scientific and epidemiologic issues when conducting environmental research.
c. Relevance of the proposed program to these and related problems. 5. Program Personnel (10 percent) a. Applicant's technical experience and understanding in the areas of PCBs, environmental epidemiology, health education/community outreach, etc. b. Qualifications and time allocation of the professional staff to be assigned to this project. c. Extent to which the management staff and their working partners are clearly described.
Applicants are required to provide measures of effectiveness that will demonstrate the accomplishment of the various identified objectives of the [[Page 32053]]
cooperative agreement. Measures of effectiveness must relate to the performance goals as stated in the Purpose section of this announcement. Measures must be objective and quantitative and must measure the intended outcome. These measures of effectiveness shall be submitted with the application.
8. Human Subjects: does the application adequately address the requirements of 45 CFR part 46 for the protection of human subjects? (Not scored; however, an application can be disapproved if the research risks are sufficiently serious and protection against risks is so inadequate as to make the entire application unacceptable.) 9. Budget Justification (Not Scored) The budget will be evaluated to the extent that it is reasonable, clearly justified, and consistent with the intended use of funds.
10. Does the application adequately address the CDC Policy requirements regarding the inclusion of women, ethnic, and racial groups in the proposed research? (Not scored.) This includes: a. The proposed plan for the inclusion of both sexes and racial and ethnic minority populations for appropriate representation.
b. The proposed justification when representation is limited or absent. c. A statement as to whether the design of the study is adequate to measure differences when warranted. d. A statement as to whether the plans for recruitment and outreach for study participants include the process of establishing partnerships with community(ies) and recognition of mutual benefits. I. Other Requirements
1. Provide CDC with an original plus two copies of an interim progress report, no less than 90 days before the end of the budget period. The progress report will serve as your noncompeting continuation application, and must contain the following elements: a. Current Budget Period Activities Objectives. b. Current Budget Period Financial Progress. c. New Budget Period Program Proposed Activity Objectives. d. Detailed LineItem Budget and Justification. e. Additional Requested Information. 2. Financial status report, no more than 90 days after the end of the budget period. 3. Final financial and performance reports, no more than 90 days after the end of the project period. Send all reports to the Grants Management Specialist identified in the ``Where to Obtain Additional Information'' section of this announcement.
The following additional requirements are applicable to this program. For a complete description of each, see Attachment I of the program announcement as posted on the CDC Web site. AR1 Human Subjects Requirements
AR2 Requirements of Inclusion of Women and Racial and Ethnic Minorities in Research AR7 Executive Order 12372 Review AR9 Paper Work Reduction Act AR10 SmokeFree Workplace Requirements AR11 Healthy People 2010 AR12 Lobbying Restrictions
AR17 Peer Review and Technical Reviews of Final Reports of Health StudiesATSDR AR18 Cost RecoveryATSDR AR19 Third Party AgreementsATSDR AR22 Research Integrity
This and other CDC announcements, the necessary applications, and associated forms can be found on the CDC web site, Internet address: http://www.cdc.gov. Click on ``Funding'' then ``Grants and Cooperative Agreements'. For general questions about this announcement, contact: Technical Information Management, CDC Procurement and Grants Office, 2920 Brandywine Rd, Atlanta, GA 303414146. Telephone: 7704882700.
For business management and budget assistance, contact: Edna Green, Grants Management Specialist, Procurement and Grants Office, Centers for Disease Control and Prevention, 2920 Brandywine Road, Atlanta, GA 303414146. Telephone: 7704882743. email address: EGreen@cdc.gov. For program technical assistance, contact: Sherri BergerFrank, Agency for Toxic Substances and Disease Registry, 1600 Clifton Road, NE., Mail Stop E28, Atlanta, Georgia 30333. Telephone: (404) 4980522. Email address: SBerger@cdc.gov; or Scott Bowen, Agency for Toxic Substances and Disease Registry, 1600 Clifton Road, NE., Mail Stop E
31, Atlanta, Georgia 30333. Telephone: (404) 4983457. Email address: msb4@cdc.gov. Dated: May 19, 2003. Sandra R. Manning,
Director, Procurement and Grants Office, Centers for Disease Control and Prevention. [FR Doc. 0313378 Filed 52803; 8:45 am]
SUMMARY: Anniston, AL; polychlorinated biphenyls exposure and adverse health effects, DOCUMENT BODY 2: Application Deadline: June 30, 2003.